amifostine anhydrous has been researched along with Hematologic Neoplasms in 6 studies
Amifostine: A phosphorothioate proposed as a radiation-protective agent. It causes splenic vasodilation and may block autonomic ganglia.
amifostine : An organic thiophosphate that is the S-phospho derivative of 2-[(3-aminopropyl)amino]ethanethiol. A prodrug for the free thiol, WR-1065, which is used as a cytoprotectant in cancer chemotherapy and radiotherapy.
Hematologic Neoplasms: Neoplasms located in the blood and blood-forming tissue (the bone marrow and lymphatic tissue). The commonest forms are the various types of LEUKEMIA, of LYMPHOMA, and of the progressive, life-threatening forms of the MYELODYSPLASTIC SYNDROMES.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Also grade III or IV infections (P=0." | 2.71 | A randomized trial of amifostine as a cytoprotectant for patients receiving myeloablative therapy for allogeneic hematopoietic stem cell transplantation. ( Chow, H; Chuah, CT; Fook, SC; Goh, YT; Hwang, WY; Koh, LP; Ng, HJ; Tan, CH; Tan, KW; Tan, PH; Wong, C, 2004) |
| "Mucositis is a significant complication of cancer therapy, with important clinical and economic implications." | 2.43 | Amifostine in the management of radiation-induced and chemo-induced mucositis. ( Bensadoun, RJ; Keefe, D; Lalla, RV; Schubert, MM, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 4 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hwang, WY | 1 |
| Koh, LP | 1 |
| Ng, HJ | 1 |
| Tan, PH | 1 |
| Chuah, CT | 1 |
| Fook, SC | 1 |
| Chow, H | 1 |
| Tan, KW | 1 |
| Wong, C | 1 |
| Tan, CH | 1 |
| Goh, YT | 1 |
| Bensadoun, RJ | 1 |
| Schubert, MM | 1 |
| Lalla, RV | 1 |
| Keefe, D | 1 |
| List, AF | 1 |
| Santini, V | 1 |
| Giles, FJ | 1 |
| Fetscher, S | 1 |
| Mertelsmann, R | 1 |
4 reviews available for amifostine anhydrous and Hematologic Neoplasms
| Article | Year |
|---|---|
Amifostine in the management of radiation-induced and chemo-induced mucositis.
Topics: Amifostine; Antineoplastic Agents; Combined Modality Therapy; Esophagitis; Evidence-Based Medicine; | 2006 |
Use of amifostine in hematologic malignancies, myelodysplastic syndrome, and acute leukemia.
Topics: Acute Disease; Amifostine; Animals; Apoptosis; Cytoprotection; Hematologic Neoplasms; Hematopoietic | 1999 |
The potential of amifostine: from cytoprotectant to therapeutic agent.
Topics: Amifostine; Animals; Antineoplastic Agents; Hematologic Neoplasms; Humans; Neutropenia; Radiation-Pr | 1999 |
Supportive care in hematologic malignancies: hematopoietic growth factors, infections, transfusion therapy.
Topics: Adult; Amifostine; Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Blood Transfusion; Bon | 2000 |
1 trial available for amifostine anhydrous and Hematologic Neoplasms
| Article | Year |
|---|---|
A randomized trial of amifostine as a cytoprotectant for patients receiving myeloablative therapy for allogeneic hematopoietic stem cell transplantation.
Topics: Adolescent; Adult; Amifostine; Antineoplastic Combined Chemotherapy Protocols; Female; Graft Surviva | 2004 |
1 other study available for amifostine anhydrous and Hematologic Neoplasms
| Article | Year |
|---|---|
Managing oral mucositis in patients with hematologic malignancies.
Topics: Amifostine; Animals; Antineoplastic Agents; Cryotherapy; Fibroblast Growth Factor 7; Hematologic Neo | 2006 |